Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I contacted U of Oxford.
They are still recruiting...
Sometime next year the stuff will be published...
Published Results 1q 18
Info from Oxford.
That means company may knwabout the outcome end of 17.
Impossible: market capitalization is $43 million....
This is what they should focus on:
Even small quantities of opioids prescribed for minor injuries increase risk of long-term use
Patients who received their first opioid prescription for an ankle sprain treated in U.S. emergency departments commonly received prescriptions for anywhere from 15 to 40 pills, according to new research. Those who received 30 or more pills compared to less than 15 pills were twice as likely to fill an additional opioid prescription within three to six months. The authors say the results point to the urgent need for policies and guidelines to address when opioid medications are indicated for minor injuries and to reduce the number of pills supplied for opioid prescriptions.
Actipatch may help to mitigate this risk, drug-free!!!
BIEL: bring on well designed studies and prove the early findings. Seriousley. Then boooom.
Not enough volume.
Not yet.
Hope sooon!!!
The focus on Opioid Epidemic is just right. They now need to bring up a well designed and powered study to show the Product to reduce the use of Opioids in a meaningful patient cohort.
Such a study, granted it reaches the primary endpoint, would for sure bring in the desired partner/licensee.
Just buy the knee type, that just work fine.
Reality Check:
It will take probably 6-9 months from now to put the Products on the Shelves.
But then off to the races!
Link?
Bishop - exactly what i think!
I really hope, they are able to work out some kind of deal, at least put the right consultants in place to do the work.
And this in a fast manner.
Pretty clear results:
They put most of their money into the Lawyers for OTC Clearance....
In this biz marketing is key - this is expensive, but generate more sales.
BIEL needs a strong partner!!!!
I guess we will get some sort of marketing and distribution PR within the next 2-3 weeks.
Probably they first need to go it alone with some sort of third party paid help
To create awareness and first sales dynamics, then hopefully big guys may step in....
What do you mean?
Chasssss
What are you doing?
I would like to see a structured deal
with a company willing to market existing products in US or globally.
But starting in US.
As well,this partner should have a clear plan for further clinical trials
with reasonable sizes (about 300-600)
To show stat sig efficacy for Actipatch to reduce opioids and nsaids.
0,05 - 0,15
They really need cash badly.
Otherwise sales will not be developed properly.
All these mentioned distributors do nothing, they are simply not effective.
And they need to come up with a new Back Pain study, which is performed
professional. Probably in US.
They also need a well designed Study
Which shows, that Actipatch decreases the need for Opioid or other Pills. Again in US.
With such studies on the horizon, a partner should be found pretty quickly.
Given good results, they are off the races.
Re: uksausage Post# 103441
What about this:
1.Biel increased AS to 20b
2.Biel has now 20% of AS to put into the game
3. Biel needs partner for marketing and key clinical trials
4. Biel offers these shares to BP
5. BP pays for clinical trials and marketing
6. BP has first right to buy Biel for given sum.
Any Discussion?
Best Pix
Report TOS
What about this:
1.Biel increased AS to 20b
2.Biel has now 20% of AS to put into the game
3. Biel needs partner for marketing and key clinical trials
4. Biel offers these shares to BP
5. BP pays for clinical trials
6. BP has first right to buy Biel for given sum.
Any Discussion?
Best Pix
This is exactly what we need!!
Exposure!!!
The mentioned clinical study on Opioid Reduction is also a wise strategy.
Go on Team Biel!!
Excellent post.
They are in talks, that takes time to find the right setting.
I am confident.
I have just put a sell order of 49000000 Shares @ 0.1 into the trading plattform.
Let us squeeze the shorts.
We are in accumulation mode.
Not sure if short covering is the driver.
This all coils the spring!
The coming move on substantial PR
will probably be more than brutal.
Will help us very soon!!!!
I am fully loaded for a nice ride until buyout.
50.000.000 long
Enjoyyyyy
My funds will get cleared tomorrow.
Will add shares too.
Hint, hint: ".....the devices are placed on the shelf and sold with aspirin and other pain relief drugs"
May be, we are closer to deal with a retailer than thought?!!!
Would not this PR suggest, that a first partner has been found and signed on?
Best Pix
Generating money needs funds.
Soooo easy.
Soon!
Best Pix
Will the gap fill????
Anyone?
I will put usd 3000 more into it.
Very looong
Pix
They simply need the money for production of inventory and first marketing campaigns.
Remember if they start marketing, they need to deliver and should not run into backlogs. This is part of the game. Anyway i hope, that they find the right partner very soon.
Then boooom.
Best Pix
I guess we will see the start of marketing activities mid/end of march.
By then they should have filled up appropriate stock of products.
Then some weeks later, we should have top line results of the Oxford study.
And at this time the closing of a first major deal should come in any day....
Booom
Best Pix
As soon as they announce such a Partner, there is Lift Off!
At least 5-10 bagger from here.
Enjoy, Pix
Ps fully loaded @ 47 000 000 shrs
My guess is, we will first see a deal with McKesson.
That woud be huge, as they will be a first and very experienced layer of distribution.
From McKesson hp:
We’re working with pharmaceutical manufacturers to help develop and deliver advanced medical treatments that lead to improved care and outcomes.
They provide everything to roll out BIELs Products effectively.
Huge thing would be to have press on Actipatch helping potentially to reduce opioid consum.
This would generate not only public interest, but also companies interest
who are selling Opioids.
Double sworded strategy...
You are on spot.
Marketing is King now.
I have not seen Ads in relevant newspapers in Austria yet.
Would be nice, to see Ads there...
Who or what is OneGlobe Biotechnology?
Not time for selling.
I will buy tomorrow for another USD 1200
Long 46.400.000
Watch out for Oxford results coming i a couple of weeks....
Yes, PE 50
Perspective:
For 10 Million Profit and corresponding 500 Million Market Cap
they need the following.
Sell 2 Million Actipatches Worldwide.
(Full version)
20000 Stores
Profit of USD 5 / patch
Sales of 8 patches per month / Store
Plus On Line Sales
That is it!!!